Glassman Wealth Services Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Glassman Wealth Services

  • $585 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022
BUY
$83.14 - $145.99 $83 - $145
1 New
1 $0
Q1 2020

May 12, 2020
SELL
$27.51 - $57.29 $27 - $57
-1 Closed
0 $0
Q4 2019

Feb 07, 2020
BUY
$40.86 - $57.65 $40 - $57
1 New
1 $0
Q3 2019

Nov 01, 2019
SELL
$37.38 - $49.47 $149 - $197
-4 Closed
0 $0
Q2 2019

Aug 08, 2019
BUY
$39.79 - $67.01 $159 - $268
4 New
4 $0

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.8B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Glassman Wealth Services Portfolio

Follow Glassman Wealth Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email